These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17361218)

  • 1. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression.
    Sengupta A; Banerjee D; Chandra S; Banerji SK; Ghosh R; Roy R; Banerjee S
    Leukemia; 2007 May; 21(5):949-55. PubMed ID: 17361218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls.
    de Cássia Viu Carrara R; Fontes AM; Abraham KJ; Orellana MD; Haddad SK; Palma PVB; Panepucci RA; Zago MA; Covas DT
    Clin Transl Oncol; 2018 Apr; 20(4):542-549. PubMed ID: 28905209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling.
    Su W; Meng F; Huang L; Zheng M; Liu W; Sun H
    Exp Hematol; 2012 May; 40(5):418-27. PubMed ID: 22240607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of WNT2B based on the balance of Hedgehog, Notch, BMP and WNT signals.
    Katoh M; Katoh M
    Int J Oncol; 2009 May; 34(5):1411-5. PubMed ID: 19360354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.
    Møller GM; Frost V; Melo JV; Chantry A
    FEBS Lett; 2007 Apr; 581(7):1329-34. PubMed ID: 17349636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.
    Coppo P; Dusanter-Fourt I; Millot G; Nogueira MM; Dugray A; Bonnet ML; Mitjavila-Garcia MT; Le Pesteur D; Guilhot F; Vainchenker W; Sainteny F; Turhan AG
    Oncogene; 2003 Jun; 22(26):4102-10. PubMed ID: 12821944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia.
    José-Enériz ES; Román-Gómez J; Cordeu L; Ballestar E; Gárate L; Andreu EJ; Isidro I; Guruceaga E; Jiménez-Velasco A; Heiniger A; Torres A; Calasanz MJ; Esteller M; Gutiérrez NC; Rubio A; Pérez-Roger I; Agirre X; Prósper F
    Br J Haematol; 2008 Aug; 142(4):571-82. PubMed ID: 18537972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
    Babashah S; Sadeghizadeh M; Hajifathali A; Tavirani MR; Zomorod MS; Ghadiani M; Soleimani M
    Int J Cancer; 2013 Aug; 133(3):579-89. PubMed ID: 23341351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
    Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia.
    Schwab R; Peschel C; Desprès D; Derigs G; Fischer T; Huber C; Aulitzky WE
    Cytokines Mol Ther; 1995 Dec; 1(4):281-8. PubMed ID: 9384681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems biology approach to model neural stem cell regulation by notch, shh, wnt, and EGF signaling pathways.
    Sivakumar KC; Dhanesh SB; Shobana S; James J; Mundayoor S
    OMICS; 2011 Oct; 15(10):729-37. PubMed ID: 21978399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.
    Jiang X; Zhao Y; Smith C; Gasparetto M; Turhan A; Eaves A; Eaves C
    Leukemia; 2007 May; 21(5):926-35. PubMed ID: 17330101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human stem cell model to study signal transduction and molecular regulation mechanisms in CML.
    Fan E; Hu Y; Zhao C
    Chin Med J (Engl); 2001 Jul; 114(7):680-4. PubMed ID: 11780326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.